Page last updated: 2024-10-25

cimetidine and Bone Diseases, Metabolic

cimetidine has been researched along with Bone Diseases, Metabolic in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lesclous, P1
Guez, D1
Saffar, JL1

Other Studies

1 other study available for cimetidine and Bone Diseases, Metabolic

ArticleYear
Short-term prevention of osteoclastic resorption and osteopenia in ovariectomized rats treated with the H(2) receptor antagonist cimetidine.
    Bone, 2002, Volume: 30, Issue:1

    Topics: Animals; Bone Diseases, Metabolic; Bone Resorption; Cell Differentiation; Cell Size; Cimetidine; Fem

2002